Last reviewed · How we verify

NCT06079034

Impact of Cannulation Strategy on Neurologic Injury in Infants With Respiratory Failure

Completed Last updated 4 April 2024
What this trial tests

trial testing Venovenous ECMO in Respiratory Failure in 5,058 participants. Completed in 12 December 2023.

Timeline
18 October 2023
Primary endpoint
12 December 2023
12 December 2023

Quick facts

Lead sponsorUniversity of Michigan
StatusCompleted
Study typeOBSERVATIONAL
Enrollment5,058
Start date18 October 2023
Primary completion12 December 2023
Estimated completion12 December 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Michigan

Who can join

0 Days and older, any sex, with Respiratory Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There has been increasing use of venoarterial (VA) extracorporeal membrane oxygenation (ECMO) for infants with respiratory failure, up to 92% of neonatal respiratory support in 2021. This study seeks to leverage the increased use of VA ECMO in this cohort to enrich an evaluation of the differences in rate of intracranial hemorrhage and ischemic stroke between venovenous (VV) and VA ECMO among infants with respiratory failure where clinicians may choose either strategy. This project is a retrospective review of data in the ELSO registry.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Venovenous ECMO

Trials testing the same drug.

Other recruiting trials for Respiratory Failure

Currently open trials in the same condition.

Other University of Michigan trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06079034.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing